£4.0M
The investment round was led by Archangels to help the life science firm advance its cell analysis platform.
C
Cytomos
Cytomos develops a proprietary technology platform for real-time cell analysis in the biopharma industry.
Edinburgh, UK
£4.0MTotal raised
Cytomos is an Edinburgh-based life science company that has developed a proprietary platform for analysing cells to support the biopharma industry.
Categories
Team
DR
David Rigterink
CEO
LF
Lindsay Fraser
CSO